Latest Articles and Analysis

Conference examines HIV and methamphetamine use intersection among MSM and transgender communities.

2020 CDC HIV surveillance reveals COVID-19's impact on HIV prevention and testing with decreased diagnoses and increased deaths.

Health misinformation undermines vaccine confidence, perpetuates stigma, and drives poor policy decisions.

CANN roundtable examines COVID-19 impacts on public health advocacy, Medicaid expansion, and HIV programs.

CANN campaign promotes transgender leadership in HIV advocacy, affirming gender-affirming care as lifesaving.

Family support predicts treatment success; policy must address intimate partner violence and health outcomes.

Access Health Louisiana uses animated series and radio to educate communities on HIV, HCV, and public health.

CANN announces 2022 organizational changes including rebranding and launching the 340B Action Center.

CANN reflects on 2021 advocacy spanning 340B drug pricing, HIV, hepatitis C, and substance use disorder policy.

New CANN leadership reflects on mentorship and maintaining advocacy legacy following Bill Arnold's passing.

Global Fund report shows COVID-19 reduced HIV/HCV program efficacy while South Africa tripled ART coverage.

31,000 Veterans with HIV face unique barriers including comorbidities and HCV rates 3x the general population.

Analysis of hepatitis B vaccine efficacy and revaccination protocols for people living with HIV.

COVID-19 strains public health efforts addressing HIV outbreaks, diverting resources from the domestic epidemic.

Post-PHE planning for Medicaid redetermination: extended timelines and navigator support for safety net care.

Study explores social-spatial networks and HIV/HCV diagnosis rates among homeless and injection drug users.

Explores the personal toll of patient advocacy, examining burnout and the need to support advocates.

CANN roundtable discusses pandemic's impacts on HIV, HCV, STI, and SUD programs and funding weaknesses.

Study of 109,283 patients links HIV status and viral hepatitis coinfection to significantly increased liver cancer rates.

Broken advocacy pipeline lacks investment in leadership development, compensation, and mentorship.